Clinical trial Recruiting at 1 site Interventional Ages 50 to 90

Mobile intervention for preventing suicide in older adults

Official title: WellPATH-PREVENT: A Mobile Intervention for Middle-Aged and Older Adults Hospitalized for Suicidal Ideation or Attempt

Run by Weill Medical College of Cornell University · NCT05183230 · Data updated 2026-11-12

This study tests a mobile program that helps older adults who have recently been hospitalized for suicidal thoughts or attempts learn to manage their emotions better and reduce their risk of suicide.

Quick facts

Study typeInterventional
Ages50 Years to 90 Years
SexAll
Enrollment115 (estimated)
SponsorWeill Medical College of Cornell University
Academic / other
Locations2 sites (New York, New York and 1 other locations)
StatusRecruiting
StartedApril 22, 2022
Main results expectedSeptember 30, 2027
Study endsSeptember 30, 2027
Registry record updatedSeptember 23, 2026
Trial IDNCT05183230 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are adults aged 50-90 who have been hospitalized for suicidal ideation or attempts and meet specific DSM-5 diagnostic criteria.

Probably not a fit

Patients with current psychotic disorders, dementia, or significant cognitive impairment may not benefit from this intervention.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This project aims to evaluate the effectiveness of WellPATH-PREVENT, a mobile psychosocial intervention designed to enhance cognitive reappraisal abilities and reduce suicide risk among middle-aged and older adults who have recently been hospitalized for suicidal ideation or attempts. The intervention will be administered over 12 weeks, with participants receiving training on using a tablet to track triggers and emotions while being coached by interventionists. The study includes multiple assessments at key points, including hospital discharge and follow-ups at 6 and 12 weeks, to monitor progress and outcomes. An EEG will also be conducted to gather additional data on emotional regulation.

Why it matters

Potential benefit: If successful, this intervention could significantly reduce suicide risk and improve emotional regulation in vulnerable older adults.

How similar studies have gone: Other studies have shown promise in using mobile interventions for mental health, but this specific approach is novel and untested in this population.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* 50-90 years old
* Diagnosis (based on a modified SCID-5 Clinical Trials Version to assess DSM-5 diagnoses): Any DSM-5 except: current diagnosis of Psychotic Disorder; diagnosis of Dementia
* Recent hospitalization for suicidal ideation or suicide attempt; at hospital admission, Columbia Suicide Severity Rating Scale (CSSR-S) ≥ 2, "Non-specific Active Suicidal Thoughts."
* We will also include patients on psychotropics and on after-care community psychotherapy.

Exclusion Criteria:

* Current diagnosis of Psychotic Disorders; Diagnosis of Dementia
* Cognitive Impairment (MMSE ≤ 24)
* Acute or severe medical illness (i.e., delirium; decompensated cardiac, liver or kidney failure; major surgery; stroke or myocardial infarction during the three months prior to entry
* Aphasia, sensory problems, and/or inability to speak English.

Where it's running

  • Weill Cornell Institute of Geriatric Psychiatry, Weill Cornell Medicine
    White Plains, New York, United States
    Recruiting
  • New York Presbyterian Hospital/Weill Cornell Medicine
    New York, New York, United States
    Not yet recruiting

Study contacts

  • Principal investigator: Dimitris Kiosses, PhD — Weill Medical College of Cornell University
  • Study coordinator: Dimitris Kiosses, PhD
  • Email: dkiosses@med.cornell.edu
  • Phone: 914-997-4381

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.